Chad V Pecot - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chad V Pecot

Showing results (71-80 of 74) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 74 results.

Nature Communications|March 13, 2014

2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activitySherry Y Wu, Xianbin Yang, Kshipra M Gharpure, et al.

Nature Communications|April 5, 2016

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancerSherry Y Wu, Rajesha Rupaimoole, Fangrong Shen, et al.

Cancer Cell|October 21, 2015

Erythropoietin Stimulates Tumor Growth via EphB4Sunila Pradeep, Jie Huang, Edna M Mora, et al.

Nature|October 9, 2024

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.

Pageof 8

Search research articles

Showing results (71-80 of 74) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 74 results.

Nature Communications|March 13, 2014

2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activitySherry Y Wu, Xianbin Yang, Kshipra M Gharpure, et al.

Nature Communications|April 5, 2016

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancerSherry Y Wu, Rajesha Rupaimoole, Fangrong Shen, et al.

Cancer Cell|October 21, 2015

Erythropoietin Stimulates Tumor Growth via EphB4Sunila Pradeep, Jie Huang, Edna M Mora, et al.

Nature|October 9, 2024

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.

Pageof 8